Dare Bioscience Q2 2024 GAAP EPS $1.52, Sales $22.438M
Portfolio Pulse from Benzinga Newsdesk
Dare Bioscience (NASDAQ:DARE) reported Q2 2024 earnings of $1.52 per share and $22.438 million in sales.
August 12, 2024 | 8:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Dare Bioscience reported strong Q2 2024 earnings of $1.52 per share and $22.438 million in sales, indicating solid financial performance.
The reported earnings per share (EPS) of $1.52 and sales of $22.438 million suggest a strong financial performance for Dare Bioscience. This positive earnings report is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100